Literature DB >> 28186095

The Role of microRNA Expression in Cortical Development During Conversion to Psychosis.

Amanda B Zheutlin1, Clark D Jeffries2, Diana O Perkins3, Yoonho Chung1, Adam M Chekroud1, Jean Addington4, Carrie E Bearden5, Kristin S Cadenhead6, Barbara A Cornblatt7, Daniel H Mathalon8, Thomas H McGlashan9, Larry J Seidman10, Elaine F Walker11, Scott W Woods9, Ming Tsuang6, Tyrone D Cannon1,9.   

Abstract

In a recent report of the North American Prodrome Longitudinal Study (NAPLS), clinical high-risk individuals who converted to psychosis showed a steeper rate of cortical gray matter reduction compared with non-converters and healthy controls, and the rate of cortical thinning was correlated with levels of proinflammatory cytokines at baseline. These findings suggest a critical role for microglia, the resident macrophages in the brain, in perturbations of cortical maturation processes associated with onset of psychosis. Elucidating gene expression pathways promoting microglial action prior to disease onset would inform potential preventative intervention targets. Here we used a forward stepwise regression algorithm to build a classifier of baseline microRNA expression in peripheral leukocytes associated with annualized rate of cortical thinning in a subsample of the NAPLS cohort (N=74). Our cortical thinning classifier included nine microRNAs, p=3.63 × 10-08, R2=0.358, permutation-based p=0.039, the gene targets of which were enriched for intracellular signaling pathways that are important to coordinating inflammatory responses within immune cells (p<0.05, Benjamini-Hochberg corrected). The classifier was also related to proinflammatory cytokine levels in serum (p=0.038). Furthermore, miRNAs that predicted conversion status were found to do so in a manner partially mediated by rate of cortical thinning (point estimate=0.078 (95% CIs: 0.003, 0.168), p=0.03). Many of the miRNAs identified here have been previously implicated in brain development, synaptic plasticity, immune function and/or schizophrenia, showing some convergence across studies and methodologies. Altered intracellular signaling within the immune system may interact with cortical maturation in individuals at high risk for schizophrenia promoting disease onset.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28186095      PMCID: PMC5603810          DOI: 10.1038/npp.2017.34

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  46 in total

1.  MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function.

Authors:  Brooke H Miller; Zane Zeier; Li Xi; Thomas A Lanz; Shibing Deng; Julia Strathmann; David Willoughby; Paul J Kenny; John D Elsworth; Matthew S Lawrence; Robert H Roth; Dieter Edbauer; Robin J Kleiman; Claes Wahlestedt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

Review 2.  MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation.

Authors:  Enikö Sonkoly; Mona Ståhle; Andor Pivarcsi
Journal:  Semin Cancer Biol       Date:  2008-01-15       Impact factor: 15.707

3.  MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders.

Authors:  Albert H Kim; Mark Reimers; Brion Maher; Vernell Williamson; Omari McMichael; Joseph L McClay; Edwin J C G van den Oord; Brien P Riley; Kenneth S Kendler; Vladimir I Vladimirov
Journal:  Schizophr Res       Date:  2010-08-02       Impact factor: 4.939

4.  Copy number variable microRNAs in schizophrenia and their neurodevelopmental gene targets.

Authors:  William Warnica; Daniele Merico; Gregory Costain; Simon E Alfred; John Wei; Christian R Marshall; Stephen W Scherer; Anne S Bassett
Journal:  Biol Psychiatry       Date:  2014-05-29       Impact factor: 13.382

5.  An entropy-based gene selection method for cancer classification using microarray data.

Authors:  Xiaoxing Liu; Arun Krishnan; Adrian Mondry
Journal:  BMC Bioinformatics       Date:  2005-03-24       Impact factor: 3.169

6.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.

Authors:  Lee P Lim; Nelson C Lau; Philip Garrett-Engele; Andrew Grimson; Janell M Schelter; John Castle; David P Bartel; Peter S Linsley; Jason M Johnson
Journal:  Nature       Date:  2005-01-30       Impact factor: 49.962

7.  Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk.

Authors:  Tyrone D Cannon; Yoonho Chung; George He; Daqiang Sun; Aron Jacobson; Theo G M van Erp; Sarah McEwen; Jean Addington; Carrie E Bearden; Kristin Cadenhead; Barbara Cornblatt; Daniel H Mathalon; Thomas McGlashan; Diana Perkins; Clark Jeffries; Larry J Seidman; Ming Tsuang; Elaine Walker; Scott W Woods; Robert Heinssen
Journal:  Biol Psychiatry       Date:  2014-06-12       Impact factor: 13.382

Review 8.  Control of the expression of inflammatory response genes.

Authors:  Jeremy Saklatvala; Jonathan Dean; Andrew Clark
Journal:  Biochem Soc Symp       Date:  2003

9.  Identification of differentially expressed microRNAs across the developing human brain.

Authors:  M N Ziats; O M Rennert
Journal:  Mol Psychiatry       Date:  2013-08-06       Impact factor: 15.992

10.  Schizophrenia risk from complex variation of complement component 4.

Authors:  Aswin Sekar; Allison R Bialas; Heather de Rivera; Avery Davis; Timothy R Hammond; Nolan Kamitaki; Katherine Tooley; Jessy Presumey; Matthew Baum; Vanessa Van Doren; Giulio Genovese; Samuel A Rose; Robert E Handsaker; Mark J Daly; Michael C Carroll; Beth Stevens; Steven A McCarroll
Journal:  Nature       Date:  2016-01-27       Impact factor: 49.962

View more
  8 in total

1.  Nicotine pretreatment alleviates MK-801-induced behavioral and cognitive deficits in mice by regulating Pdlim5/CRTC1 in the PFC.

Authors:  Qian Wang; Meng-Wei Wang; Yan-Yun Sun; Xiao-Yan Hu; Pan-Pan Geng; Hui Shu; Xiao-Na Wang; Hao Wang; Jun-Fang Zhang; Hong-Qiang Cheng; Wei Wang; Xin-Chun Jin
Journal:  Acta Pharmacol Sin       Date:  2022-08-29       Impact factor: 7.169

2.  TSPO expression and brain structure in the psychosis spectrum.

Authors:  Sina Hafizi; Elisa Guma; Alex Koppel; Tania Da Silva; Michael Kiang; Sylvain Houle; Alan A Wilson; Pablo M Rusjan; M Mallar Chakravarty; Romina Mizrahi
Journal:  Brain Behav Immun       Date:  2018-06-12       Impact factor: 7.217

Review 3.  Non-Coding RNA as Novel Players in the Pathophysiology of Schizophrenia.

Authors:  Andrew Gibbons; Madhara Udawela; Brian Dean
Journal:  Noncoding RNA       Date:  2018-04-12

Review 4.  MicroRNAs in the Onset of Schizophrenia.

Authors:  Kristen T Thomas; Stanislav S Zakharenko
Journal:  Cells       Date:  2021-10-06       Impact factor: 6.600

5.  A greedy regression algorithm with coarse weights offers novel advantages.

Authors:  Clark D Jeffries; John R Ford; Jeffrey L Tilson; Diana O Perkins; Darius M Bost; Dayne L Filer; Kirk C Wilhelmsen
Journal:  Sci Rep       Date:  2022-03-31       Impact factor: 4.379

6.  Neurodevelopment regulators miR-137 and miR-34 family as biomarkers for early and adult onset schizophrenia.

Authors:  Bao-Yu Chen; Jin-Jia Lin; Ming-Kun Lu; Hung-Pin Tan; Fong-Lin Jang; Sheng-Hsiang Lin
Journal:  NPJ Schizophr       Date:  2021-07-05

7.  Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis.

Authors:  David Fraguas; Covadonga M Díaz-Caneja; Miriam Ayora; Fabián Hernández-Álvarez; Alberto Rodríguez-Quiroga; Sandra Recio; Juan C Leza; Celso Arango
Journal:  Schizophr Bull       Date:  2019-06-18       Impact factor: 7.348

8.  An epigenetic biomarker for adult high-functioning autism spectrum disorder.

Authors:  Ryo Kimura; Masatoshi Nakata; Yasuko Funabiki; Shiho Suzuki; Tomonari Awaya; Toshiya Murai; Masatoshi Hagiwara
Journal:  Sci Rep       Date:  2019-09-20       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.